Evidence map›Paper›PMID 32676438›Full record

ReviewTranslational andrology and urology2020

Current techniques of prostate biopsy: an update from past to present.

Mohamed Essam Noureldin, Martin J Connor, Nicholas Boxall, Saiful Miah, Taimur Shah, Jochen Walz

Abstract readReview
In one paragraph

Review in Translational andrology and urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed Essam NoureldinImperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
Martin J ConnorImperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
Nicholas BoxallDepartment of Urology, Cambridge University Hospitals, Cambridge, UK.
Saiful MiahDepartment of Urology, Cambridge University Hospitals, Cambridge, UK.
Taimur ShahImperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
Jochen WalzDepartment of Urology, Institut Paoli-Calmettes Cancer Centre, Marseille, France.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Knowing the demerits of the transrectal ultrasound guided biopsy has led to a shift in the general techniques and technology of the prostate biopsy. In addition, the advances in magnetic resonance imaging (MRI) sensitivity and the evidence from the PROMIS trial about its ability to detect clinically significant tumours encourage urologists and industry to implement MRI-guided targeted biopsy. However, the science is still looking how to improve safety and increase its cancer detection rate (CDR).

Indexed as

biopsygrademagnetic resonance imaging (MRI)Prostate cancerprostate neoplasm

Identifiers

PMID32676438
PMCPMC7354294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.